The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Progenics Pharmaceuticals, Inc.

Progenics Pharmaceuticals, Inc.
Nasdaq: PGNX
Change
symbol:
     
 PROFILE
Progenics Pharmaceuticals runs the gamut from A to C: It is developing drugs to combat HIV and several cancers. The firm is working with Bristol-Myers Squibb to develop vaccines for melanoma and other cancers. Also in the pipeline are PRO 542, designed to prevent HIV from infecting healthy cells by bonding with the virus before it strikes the cells, and PRO 367, designed to kill HIV-infected cells. Partners in its HIV research include Pharmacopeia and American Home Products. Progenics' pipeline includes the letter "s": It is developing an antioxidant to treat stroke. Investment firm Tudor Group owns a majority of the company.

 COMPETITION
Corixa Corporation (CRXA)
Trimeris, Inc. (TRMS)
VaxGen, Inc. (VXGN)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 9.80
1-Yr. Sales Growth: (38.8)%
Employees: 54
Revenue per employee: $181,481.48

 KEY PEOPLE
• Paul J. Maddon
    CEO
• Robert A. McKinney
    CFO

 CONTACT INFO
777 Old Saw Mill River Rd.
Tarrytown, NY 10591
US
Phone: 914-789-2800
Fax: 914-789-2817
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001